Article
Patients’ Preferences for Genomic Diagnostic Testing in Chronic Lymphocytic Leukaemia: A Discrete Choice Experiment
11 May 2016
Abstract excerpt
BACKGROUND: Genomic information could help to reduce the morbidity effects of inappropriate treatment decisions in many disease areas, in particular cancer. However, evidence of the benefits that patients derive from genomic testing is limited. This study evaluated patient preferences for genomic testing in the context of chronic lymphocytic leukaemia (CLL). METHODS: We used a discrete choice experiment (DCE)...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
